GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals

In recent years, synthetic peptides have been considered promising targets for drug development that possess low side-effects, are cost-effective and are susceptible to rational design. Hecate was initially described as a potent bacterial inhibitor and subsequently as an anticancer drug with functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Mariana Nogueira, Sanches, Paulo Ricardo da Silva, Carneiro, Bruno Moreira, Braga, Ana Cláudia Silva, Campos, Guilherme Rodrigues Fernandes, Cilli, Eduardo Maffud, Rahal, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156508/
https://www.ncbi.nlm.nih.gov/pubmed/30254334
http://dx.doi.org/10.1038/s41598-018-32176-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156508/
https://www.ncbi.nlm.nih.gov/pubmed/30254334
http://dx.doi.org/10.1038/s41598-018-32176-w

Ejemplares similares